SERI Lugano Launches International Scientific Outreach Initiative on Light-Based Neuroscience and Pineal Gland Research
18.5.2026 16:38:00 EEST | Business Wire | Press release
As scientific interest in light-based stimulation, neuroendocrine regulation, and integrative medicine continues to grow internationally, the Switzerland Eye Research Institute (SERI Lugano) has launched a new international scientific outreach initiative focused on public engagement and interdisciplinary research communication in neuroscience and cellular modulation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260515840289/en/
Ophthalmologist Roberto Pinelli explains, in an engaging personal narrative style, his unique methods for using a combination of light, sound, and nutraceuticals to non-invasively activate the pineal gland to promote cellular rejuvenation, decrease aging, and improve overall well-being. Supported by case studies and peer-reviewed research, Pinelli’s method centers on using photons to convey vibrational energy through the eyes to target areas of the body with the sinergic use of sound vibrations and specific nutraceuticals. He shows the potent effects this has on overall wellbeing and mental health as it can improve memory, mental clarity, and self-awareness. His techniques also have positive effects on the body such as helping to heal degenerative diseases like AMD, retinal degenerations, Alzheimer’s, rheumatoid arthritis, and Parkinson’s.
The initiative aims to promote broader understanding of emerging research involving photobiomodulation, circadian biology, neuroendocrine processes, and the interaction between light, sound frequencies, and cellular function.
As part of this initiative, SERI Lugano is supporting the international publication and distribution of Awakening the Pineal Gland – Cellular Rejuvenation through Light and Sound, a new volume written by SERI Lugano founder and director Roberto Pinelli and published in the United States by Inner Traditions.
The pineal gland, a neuroendocrine structure historically associated with circadian regulation and melatonin production, has increasingly become an area of scientific interest in studies exploring the relationship between light exposure, brain activity, metabolism, and cellular signaling. Recent developments in neuroscience and photobiomodulation research have contributed to renewed attention toward the biological role of light in human physiology.
Photobiomodulation — a treatment that delivers intermittent low-frequency light through the pupillary foramen with the aim of modulating specific cellular functions — represents one of the areas explored within the initiative, together with infrasound stimulation and nutraceutical support strategies.
Researchers and clinicians affiliated with SERI Lugano are currently investigating the interaction between light-based stimulation, mitochondrial activity, circadian mechanisms, and neuroendocrine regulation, with particular attention to potential applications in integrative and regenerative medicine (Pinelli R. et al, “Combined pulses of light and sound in the retina with nutraceuticals may enhance the recovery of foveal holes”. Archives Italiennes de Biologie, 160: 3-21, 2022).
The initiative also promotes interdisciplinary dialogue between contemporary scientific investigation and historical perspectives on light and consciousness found in ancient civilizations, including Egyptian and Sumerian traditions. According to SERI Lugano, revisiting historical interpretations of human physiology may contribute to broader cultural reflection alongside modern scientific research.
“Scientific communication should help create bridges between advanced research, clinical observation, and public understanding,” said Roberto Pinelli, founder and director of SERI Lugano. “Our goal is to encourage interdisciplinary dialogue around the role of light, neuroscience, and cellular function in human physiology.”
The initiative reflects SERI Lugano’s broader commitment to integrating ophthalmology, neuroscience, photobiomodulation, and cellular research within an international scientific and educational framework.
The volume Awakening the Pineal Gland is distributed in the United States by Simon & Schuster and is available through major international platforms, including Amazon.com.
About Switzerland Eye Research Institute (SERI Lugano)
The Switzerland Eye Research Institute (SERI Lugano), based in Lugano, Switzerland, is an independent research and clinical institute focused on ophthalmology, neuroscience, photobiomodulation, and interdisciplinary research involving light-based technologies, neuroendocrine regulation, and cellular function.
The institute promotes integrative approaches combining clinical activity, scientific research, and public scientific communication.
Learn more:
www.seri-lugano.ch
View source version on businesswire.com: https://www.businesswire.com/news/home/20260515840289/en/
Contacts
Media Contact
Switzerland Eye Research Institute (SERI Lugano)
Lugano, Switzerland
E-mail: info@seri-lugano.ch
Tel.: +41 91 993 13 01
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Infobip Named a Leader in the 2026 Gartner® Magic Quadrant™ for Communications Platform as a Service18.5.2026 17:25:00 EEST | Press release
Infobip is excited to share that global AI-first cloud communications platform Infobip has been recognized as a Leader in the 2026 Gartner Magic Quadrant for Communications Platform as a Service. Check back for a complimentary copy of the full report soon! In Infobip’s view, this recognition reflects what the company has spent 20 years building: a communications platform that stays focused on what customers actually need and evolves as markets change. Infobip believes that recognition in a fast-moving market comes not from chasing trends, but from disciplined execution and a clear long-term vision. As Infobip marks its 20th year of operations, the company thinks the shift to agentic AI represents the most significant transformation in customer communications in our history. Infobip believes enterprises need a partner that empowers them to move from campaigns and rigid workflows to autonomous, goal-driven interactions, while retaining the openness and flexibility to adapt as the technol
Seoul Design Foundation Announces ‘Seoul Design AI Film Festival’ Call for Entries18.5.2026 17:00:00 EEST | Press release
The Seoul Design Foundation (CEO Cha Kang Heui) is inviting visionaries worldwide to the Seoul Design AI Film Festival (SDAFF). This global competition aims to redefine the Dongdaemun Design Plaza (DDP)—the world’s largest atypical architecture—as a premier destination for AI-driven media art. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260518044745/en/ An official poster for Seoul Design AI Film Festival (Image: Seoul Design Foundation) The DDP’s 222-meter curved exterior wall, a Guinness World Record holder for the "World's Largest 3D Mapping on an Atypical Building," will serve as the digital canvas for the winners. ‘Seoul Light DDP’ has already achieved global acclaim by winning the world’s top three design awards: iF, Red Dot, and IDEA. Bridging AI Technology and K-Culture The festival seeks high-quality video works that blend artistic inspiration with cutting-edge AI technology. The competition features two main cat
TwentyTwo Real Estate to Acquire Terhills Resort in Belgium from LRM18.5.2026 16:00:00 EEST | Press release
TwentyTwo Real Estate, an independent European real estate investment and management firm, announces it has agreed to acquire Terhills Resort in Belgium from LRM. The transaction is expected to close on 29 May 2026. Operated by Center Parcs, the premium holiday park spans 63 hectares and comprises 250 waterfront cottages alongside central leisure facilities, set within a unique natural environment at the gateway to Hoge Kempen National Park. Center Parcs will remain the operator of the resort for at least the next 10 years, ensuring continuity for guests and supporting the long-term positioning of the resort as a leading leisure destination in Limburg, one of Flanders’ most distinctive tourism regions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513424487/en/ Opened in 2021, Terhills Resort forms part of the broader long-term transformation of the surrounding area into a leading nature, tourism and leisure destination.
Thermo Fisher Scientific’s PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden18.5.2026 15:30:00 EEST | Press release
Thermo Fisher Scientific, the world leader in serving science, today announced the opening of a new bioanalytical and biomarker laboratory in Gothenburg, Sweden, located within GoCo Health Innovation City. This new facility expands the company’s global bioanalytical capabilities to support pharmaceutical and biotechnology customers across all phases of drug development. With state-of-the-art instrumentation and Good Laboratory Practice (GLP) capabilities, the laboratory provides rapid, reliable bioanalytical and biomarker services across the full drug development lifecycle, from preclinical studies through post-approval. Its advanced technology suite includes cell-based assays, immunochemistry, liquid chromatography-mass spectrometry, molecular genomics, flow cytometry and proteomics, supporting both small molecules and complex therapeutic modalities such as peptides, antibodies, oligonucleotides, and cell and gene therapies. “Our new Gothenburg laboratory is purpose-built to address t
HistoSonics Receives Landmark TFDA Approval in Taiwan, Accelerating Global Expansion18.5.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced it has received approval from the Taiwan Food and Drug Administration (TFDA) for the Edison® System, representing a significant milestone in the company’s global expansion efforts and continued growth across Asia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260518694013/en/ HistoSonics Edison® Histotripsy System Taiwan is widely recognized as one of the most advanced and strategically important medical device markets in the region, known for its rigorous regulatory standards and highly innovative physician community. The TFDA approval process included a detailed review of the company’s clinical and regulatory submission package and concluded with unanimous agreement from committee members. The approval further reinforces the growing clinical and regulatory momentum behind histotripsy, a non-invasive, non-th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom